On the contamination of commercially available aprotinins with pancreatic islet peptides

References

• Albano J. D.M., Ekins R. P., Maritz G., Turner R. C. A sensitive precise radioimmunoassay for serum insulin relying on charcoal separation of bound and free hormone moieties. Ada Endrocrinol. (Copenh.) 1972; 70: 487
   PubMedGoogle Scholar
• Back N. Death from acute pancreatitis. Lancet 1978; ii: 370
   Google Scholar
• Baldissera F. G.A., Munoz‐Perez M. A., Hoist J. J. Somatostatin 1–28 circulates in human plasma. Regul. Ppt. 1983; 6: 63
   PubMedGoogle Scholar
• Bethge N., Diel F., Usadel K. H. Somatostntin. A regulatory peptide of clinical importance. J. clin. Chem. clin. Biochem. 1982; 20: 603
   PubMedGoogle Scholar
• Demol P., Hotz J., Trompetter R., Benninghof J., Goebbel H. Somatostatin (SST) and calcitonin (CT) suppress the interdigestive gastric, pancreatic and biliary secretions and accelerate the interdigestive migrating motor complex (IMMC) in humans (Abstr.). Digestion 1983; 28: 20
   Web of Science ®Google Scholar
• Donaldson L. A., Schenk W. G. The effect of Trasylol and vasopressin on experimental pancreatitis. Surg. Gynecol. Obster. 1980; 150: 657
   PubMedGoogle Scholar
• Frey E. K. Zur Therapie der Pankreatitis. Therapiewoche 1953–1954; 4: 323
   Google Scholar
• Funovics J., Holbling N., Rawhs R., Pointner H., Niebauer G., Kopf N. The effect of SST, glucagon, calcitonin and PGE, on exocrine pancreatic secretion in the unrestrained dog in long‐term experiments. Eur. Surg. Res. 1981; 13: 213
   PubMed Web of Science ®Google Scholar
• Haberland G. L. Zur Wirksamkcit von Trasylol bei der Behandlung der akuten Pankreatitis. Med. Welt 1974; 29: 2112
   Google Scholar
• Haberland G. L., McConn R. A. Rationale for the therapeutic action of aprotinin. Fed. Proc. 1974; 38: 2760
   Google Scholar
• Hilsted L., Hoist J. J. On the accuracy of radioimmunological determinations of somatostatin in plasma. Regul. Pep. 1982; 4: 13
   PubMedGoogle Scholar
• Holst J. J. Evidence that glicentin contains the entire sequence of glucagon. Biochem. J. 1980; 187: 337
   PubMed Web of Science ®Google Scholar
• Imrie C. W., Benjamin I. S., Ferguson J. C., McKay A. J., McKenzic I., O'Neill J., Bluingart R. H. A single center double‐blind trial of Trasylol therapy in primary acute pancreatitis. Br. J. Surg. 1978; 65: 337
   PubMed Web of Science ®Google Scholar
• Jørgensen K. H., Larsen U. D. Purification of 125I‐glucagon by anion exchange chromatography. Horm. Metab. Res. 1972; 4: 223
   PubMed Web of Science ®Google Scholar
• Kayassch I., Gyr K., Stalder G. A., Altgöwer M. Konservative Therapie der akute UIkusblutung mit Sometostatin. Sdiwoiz. Med. Wochenschr. 1978; 108: 1083
   Google Scholar
• Knuhtsen S., Holts J. J., Knigge U., Olesen M., Nielsen O. V. Radioimmunassay.: pharmacokinetics and neuronal release of gastrin releasing peptide in anesthetized pigs. Gastroenterology 1984; 87: 372
   PubMed Web of Science ®Google Scholar
• Konturek S. J., Tasler J., Obtlowiez W., Coy D. H., Schally A. V. Effect of growth hormonerelease inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J. clin. Invest. 1976; 58: 1
   PubMed Web of Science ®Google Scholar
• Lin T. M., Evans D. C., Shaar C. J., Root M. A. Action of somatostatin on stomach, pancreas. gastric mucosal blood flow, and hormones. Am. J. ‐Physiol. 1983; 244: G40
   PubMed Web of Science ®Google Scholar
• McDonald T. J., Jörnavall H., Nilsson G., Vagne M., Gathei M., Bloom R. S., Mutt V. Characterization of a gastrin releasing peptide from porcine non‐antral gastric tissue. Biochem. biophys. Res. Commun. 1979; 90: 227
   PubMed Web of Science ®Google Scholar
• Mann N. S., Wolter C. F., Mann S. K., Kadian R. S. Enterokinase induced pancreatitis: its prevention with Trasylol and soybean trypsin inhibitor. Am. J. Proctol. Gastroenterol. Colon. Rectal. Surg. 1978; 29: 13
   PubMedGoogle Scholar
• Meyers W. C., Hanks J. B., Jones R. S. Inhibition of basal and meal‐stimulated choleresis by somatostatin. Surgery 1979; 86: 301
   PubMed Web of Science ®Google Scholar
• Moody A. J., Holst J. J., Thim L., Jensen S. L. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas. Nature 1981; 289: 514
   PubMed Web of Science ®Google Scholar
• Moody A. J., Thim L. The relationship between glucagon and gut glucagon‐like immunoreactants (gut GLIs). Gut Hormones, S. R. Bloom, J. M. Polak. Churchill‐Livingstone, Edinburgh 1981; 312–319
   Google Scholar
• Prinz R. A., Izquierdo R., Sandberg L., Squillaci D., Hoppenstead D., Walenga J., Fareed J. Use of protease inhibitors to alter coagulation abnormalities in acute canine pancreatitis (abstr.). Digestion 1983; 28: 54
   Web of Science ®Google Scholar
• Schwartz T. W., Holst J. J., Fahrenkrug J., Jensen S. L., Nielsen O. V., Rehfeld J. F., Schaffalitzky de Muckadell O. B., Stadil F. Vagal, cholinergic regulation of pancreatic polypeptide secretion. J. din. Invest. 1978; 61: 781
   PubMed Web of Science ®Google Scholar
• Schwartz T. W., Tager H. S. Isolation and biogenesis of a new peptide from pancreatic islands. Nature 1981; 294: 589
   PubMed Web of Science ®Google Scholar
• Sipilä R., Louhija A. Aprotinin in acute pancreatitis: effect on the plasma kallikreinkinin system. Acta med. scand. 1982; 668: 118
   Google Scholar
• Sunby F., Jacobsen H., Moody A. J. Purification and characterization of a protein from porcine gut with glucagon‐like immunoreactivity. Horm. Metab. Res. 1976; 8: 366
   PubMed Web of Science ®Google Scholar
• Tanaka N., Tsuchiya R., Ishii K. Comparative clinical study of FOY and Trasylol in acute pancreatitis. Adv. exp. Med. Biol. 1979; 120B: 367
   PubMedGoogle Scholar
• Thim L., Moody A. J. The primary structure of porcine glicentin (proglucagon). Regul. Pept. 1981; 2: 139
   PubMedGoogle Scholar
• Trapnell J. E., Rigby C. C., Talbot C. H., Duncan E. H.L. A controlled trial of Trasylol in the treatment of acute pancreatitis. Br. J. Surg. 1974; 61: 177
   PubMed Web of Science ®Google Scholar
• Wünsch E., Moroder L., Gemeiner M., Jaeger E., Ribet A., Pradayrol L., Vaysse N. Total Synthese von Somatostatin‐28. Z. Naturforsch. 1980; 35b: 911
   Google Scholar